Jaa Roberson
Oficial de Recursos Humanos en DAY ONE BIOPHARMACEUTICALS, INC. .
Cargos activos de Jaa Roberson
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DAY ONE BIOPHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 13/09/2021 | - |
Historial de carrera de Jaa Roberson
Antiguos cargos conocidos de Jaa Roberson.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BELLICUM PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 01/05/2018 | 01/11/2020 |
ACHAOGEN | Oficial de Recursos Humanos | - | - |
Formación de Jaa Roberson.
Rice University | Undergraduate Degree |
San Francisco Conservatory of Music | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Human Resources Officer | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Jaa Roberson
- Experiencia